首页> 外文会议>Medical Informatics in Europe Conference. >Evaluation of compliance with recommendations of prevention of thromboembolism in atrial fibrillation in the elderly, by data reuse of electronic health records
【24h】

Evaluation of compliance with recommendations of prevention of thromboembolism in atrial fibrillation in the elderly, by data reuse of electronic health records

机译:通过电子健康记录的数据重用评估遵守预防老年心房颤动的血栓栓塞建议的建议

获取原文

摘要

Under-prescription of anticoagulants in the elderly with atrial fibrillation (AF) has been described in several studies, showing that only 15 to 44% of them receive anticoagulants. However, the European Society of Cardiology recommendations state that anticoagulants should be systematically prescribed. In case of refusal of the treatment by the patient, a platelet aggregation inhibitor should be prescribed in monotherapy or bitherapy according to the HAS-BLED bleeding risk score. In all the cases the patient should receive an antithrombotic treatment. In this work we observe the adequacy of prescription practices to the recommendations for AF in the elderly by data reuse on a monocentric observational retrospective cohort. Data of a 222 beds French community hospital were extracted for the year 2013. The patients aged over 75 years and presenting AF were selected. The HAS-BLED score was calculated and the consistency of the prescriptions with the recommendations of the European Society of Cardiology was verified. Then the compliance rate to the recommendations was calculated. The rules detected 433 patients with AF and aged over 75 years. From those patients, 45% received an anticoagulant, 32.1% received platelet aggregation inhibitors and 22.9% did not receive any antithrombotic treatment. When a platelet aggregation inhibitor was prescribed the recommendation for bitherapy was not followed in 97% of the cases. The compliance rate to the recommendations was 47.8%. This work highlights a major problem of quality of the prescriptions in the hospital field and shows how data reuse can help describing this type of issues.
机译:在几项研究中描述了老年人抗凝剂(AF)的抗凝血剂的处方,表明其中只有15至44%的抗凝血剂。然而,欧洲心脏病学建议说明抗凝血剂应系统地规定。在患者拒绝治疗的情况下,应根据具有Bled Bleeding风险评分的单药治疗或斑栖规定血小板聚集抑制剂。在所有情况下,患者应接受抗血栓检查。在这项工作中,我们通过在单眼观察回顾队列上的数据重用来遵守方面对老年人建议的方面的适用性。 2013年提取了222张床床法国社区医院的数据。75岁以上的患者并选择AF。验证了具有BLED得分,并核实了欧洲心脏病学会建议的处方的一致性。然后计算建议的合规率。该规则检测到433例AF和75岁以上的患者。从那些患者中,45%接受抗凝血剂,32.1%接受血小板聚集抑制剂,22.9%没有接受任何抗血栓形成治疗。当规定血小板聚集抑制剂时,在97%的病例中,不遵循斑藻的建议。建议的合规率为47.8%。这项工作突出了医院领域处方质量的主要问题,并显示了数据重用如何帮助描述这种类型的问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号